Effects of monosialoganglioside on a new model of tardive dyskinesia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 21, Issue 7, 1997, Pages 1169-1179

  Vital, Maria A B F ^a   Frussa Filho, Roberto ^b   Palermo Neto, João ^c  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gangliosides; GM1; Monosialoganglioside (GM1); Reserpine (RES); Saline (SAL)

Indexed keywords

MONOSIALOGANGLIOSIDE; RESERPINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; TARDIVE DYSKINESIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPSYCHOTIC AGENTS; DISEASE MODELS, ANIMAL; DYSKINESIA, DRUG-INDUCED; FREE RADICALS; G(M1) GANGLIOSIDE; MALE; MOTOR ACTIVITY; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RESERPINE; TONGUE;

EID: 0030723416     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(97)00108-5     Document Type: Article

References (48)

1. AGNATI, L. F.; FUXE, K.; BENFENATI, F.; BATTISTINI, N.; ZINI, I. and TOFFANO, G. (1983) Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment. Neurosci. Lett. 40:293-297.
2. 1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats. Psychopharmacol. 116:517-522.
3. BALDESSARINI, R. J. and TARSY, D. (1979) Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia. Int. Rev. Neurobiol. 21:1-45.
4. BENZI, G. and MORETTI, A. (1995) Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radical Biology & Medicine, 19:77-101.
5. BERNARDI, M. M. and PALERMO-NETO, J. (1979) Effects of abrupt and gradual withdrawal from long-term haloperidol treatment on openfield behavior of rats. Psychopharmacol. 65:247-250.
6. BERNARDI, M. M.; DE SOUZA, H. and PALERMO-NETO, J. (1981) Effects of single and longterm haloperidol administration on open-field behavior of rats. Psychopharmacol. 73:171-175.
7. BURT, D. R.; CREESE, I. and SNYDER, S. H. (1977) Antischizophrenic drugs: Chronic treatment elevates dopaminergic receptor in brain. Science, 196:326-327.
8. CASEY, D.E. (1995) Tardive dyskinesia - Pathophysiology. In: Psychopharmacology: The Fourth generation of Progress, F.E Bloom and D. J. Kupfer (Eds.), pp 1497-1502, Raven Press Ltd, New York.
9. COYLE, J. T. and PUTTFARCKEN, P. (1993) Oxidative stress, glutamate and neurodegenerative disosrders. Science, 262:689-695.
10. EGAN, M. F.; HYDE, T. M; ALBERS, G. W.; ELKASHEF, A.; ALEXANDER, R. C.; REEVE, A.; BLUM, A.; SAENZ, R. E. and WYATT, R. J. (1992) Treatment of tardive dyskinesia with vitamin E. Am. J. Psychiat. 149:773-777.
11. ELKASHEF, A. M.; RUSKIN, P. E.; BACHER, N. and BARRET, D. (1990) Vitamin E in the treatment of tardive dyskinesia. Am. J. Psychiat. 147:505-506.
12. FAVARON, M.; MANEV, H.; ALHO, H.; BERTOLINO, M.; FERRET, B.; GUIDOTTI, A. and COSTA, E. (1988) Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc. Natl. Acad. Sci. USA, 85:7351-7355.
13. FELÍCIO, L. F.; NASELLO, A. G. and PALERMO-NETO, J. (1987) Dopaminergic supersensitivity after long-term bromopride treatment. Physiol. Behav. 41:433-437.
14. FRUSSA-FILHO, R. and PALERMO-NETO, J. (1988) Effects of single and long-term administration metoclopramide on open-field and stereotyped behavior of rats. European J. Pharmacol. 149:323-329.
15. FRUSSA-FILHO, R. and PALERMO-NETO, J. (1990) Effects of single and long-term of sulpiride administration on open-field and stereotyped behavior of rats. Braz. J. Med. Biol. Res. 23:463-472.
16. FRUSSA-FILHO, R. and PALERMO-NETO, J. (1991) Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats. Physiol. Behav. 50:825-830.
17. GAMBLE, S. J. and WADDINGTON, J. L. (1981) Multiplicity of dopamine-mediated behaviours during six months phenothiazine neuroleptic treatment in young but not aged-rats. Brit. J. Pharmacol. 74:225
18. JOHNSON, N. and LEONE, F. (1974) Statistic and experimental design. In: Engineering and physical sciences. J. Wiley (Ed.), New York.
19. JORGENSEN, H. R.; ANDREASSEN, O. A. and HOLE, K. (1994) The relationship between motor effects in rats following acute and chronic haloperidol treatment. Psychopharmacol. 116:89-92.
20. KANE, J. M.; WOERNER, M. and LIEBERMAN, J. (1985) Tardive dyskinesia: prevalence, incidence and risk factors. In: Dyskinesia: Research and Treatment. D. E. Casey, T. N. Chase, A. V. Christensen and J. Gerlach (Eds.), pp 72-78, Springer-Verlag, Berlim.
21. KANE, J. M. (1995) Tardive dyskinesia: epidemiological and clinical presentation. In: Psychopharmacology: The Fourth generation of Progress, F. E. Bloom and D. J. Kupfer (Eds.), pp 1485-1495, Raven Press Ltd, New York.
22. KLAWANS, H. L. (1973) The pharmacology of tardive dyskinesia. Am. J. Psychiat. 130:82-86.
23. LOHR, J. B.; CADET, J. L.; LOHR, M. A.; JESTE, D. V. and WYATT, R. J. (1987) Alphatocopherol in tardive dyskinesia. Lancet, 1:913-914.
24. LOHR, J. B. (1991) Oxygen free radicals and neuropsychiatric illness. Arch. Gen. Psychiat. 48:1097-1106.
25. MAK, T.; BOEHME, P. and WEGLICKI, W. B. (1992) Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Circulation Res. 70:1099-1103
26. MANEV, H.; FAVARON, M. AND VICINI, S., GUIDOTTI, A. and COSTA, E. (1990) Glutamate induced neuronal death in primary cultures of cerebellar granulle cells: Protection by synthetic derivatives of endogenous sphingolipids. J. Pharmacol. Exp. Therap. 252:419-427.
27. MAULIK, N.; DAS, D. K.; GOGINENI, M.; CORDIS, G. A.; AVROVA, N. and DENISOVA, N. (1993) Reduction of myocardial ischemic reperfusion injury by sialylated glycosphingolipids, gangliosides. J. Cardiovasc. Pharmacol. 22:74-81.
28. 1 ganglioside administration partially counteracts the morphological changes associated with haloperidol treatment within the dorsal striatum of the rat. Psychopharmacol. 121:461-469.
29. MISRA, C. H.; SHELAT, H. and SMITH, R. C. (1982) Age affects dopamine receptors changes during chronic administration of fluphenazine. Eur. J. Pharmacol. 85:343-346.
30. NEISEWANDER, J. L.; LUCKI, I. and MCGONIGLE, P. (1991a) Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment. Brain Res. 558:27-35.
31. NEISEWANDER, J. L.; LUCKI, I. and MCGONIGLE, P. (1991b) Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats. J. Pharmacol. Exp. Ther. 257:850-860.
32. NEISEWANDER, J. L.; CASTAÑEDA, E. and DAVIS, D. A. (1994) Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia. Psychopharmacol. 116:79-84.
33. NICOLETTI, F.; CAVALLARO, S.; BRUNO, V.; VIRGILI, M.; CATANIA, M. V., CONTESTABILE, A. and CANONIGO, P. L. (1989) Gangliosides attenuate NMDA receptor-mediated excitatory amino acid release in cultures cerebellar neurons. Neuropharmacol. 28:1283-1286.
34. PALERMO-NETO, J. (1982) Supersensitivity, drug withdrawal, and open-field behavior. Psychopharmacol. Bull. 18:11-12, 1984.
35. POEGGELER, B.; REITER, R. J.; TAN, D. T.; CHEN, L. D. and MANCHESTER, L. C. (1993) Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis. J. Pineal Res. 14:151-168.
36. RANDALL, P. K.; SEVERSON, J. A. and FINCH, C. E. (1981) Aging and the regulation of striatal dopaminergic mechanism in mice. J. Pharmacol. Exp. Ther. 219:695-700.
37. ROLSTEN, C.; CLAGHORN, J. and SAMORAJSKI, T. (1979) Long-term treatment with clozapine on aging mice. Life Sci. 25:865-872.
38. RUBOVITS, R. and KLAWANS, H. L. (1972) Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias. Arch. Gen. Psychiat. 27:502-507.
39. SCHRÖDER, U.; SCHRÖDER, H.; AUGUSTIN, W. and SABEL, B. A. (1994) Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding. J. Pharmacol. Exp. Therap. 271:1193-1196.
40. SEE, R. E. and CHAPMAN, M. A. (1994) Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. Europ. J. Pharmacol. 263:269-276.
41. SHONECKER, M. (1957) Ein eigentumliches syndrom in eralen Bereich bei. Megaphen Applikation Nervenartz, 28:34.
42. SIEGEL, S. (1956) Nonparametric statistic for the behavioral sciences. pp 117-127,Mc Graw-Hill, New York.
43. UHRBRAND, L. and FAURBYE, A. (1960) Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacologia, 1:408-418.
44. 1 on dopaminergic supersensitivity. Life Sci. 56(26):2299-2307.
45. WADDINGTON, J. L. and GAMBLE, S. J. (1980) Differential effects of ageing on distincts features of apomorphine stereotypy in the adult rat. Neurosci. Lett. 20:95-99.
46. WADDINGTON, J. L. (1990) Spontaneous orofacial movements induced in rodents by very longterm neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacol. 101:431-447.
47. WOLFARTH, S. and OSSOWSKA, K. (1989) Can supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia ? Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 13:789-840.
48. YAMAMOTO, B.K. and COOPERMAN, M.A. (1994) Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci. 14:4159-4166.